Visiomed raising capital for overseas expansion
You have no credits left. To view this article subscribe to Business News.
You have used {{points}} and have {{current_points}} remaining. Your credits will reset on {{reset_date}}.
This article is part of a special report and is available to paid Business News subscribers only.
You can purchase access to this special report or subscribe to Business News.
You can purchase access to this special report or subscribe to Business News.
This article is premium content and is available to paid Business News subscribers only.
Subscribe to Business News.
Subscribe to Business News.
Tuesday, 29 November, 2005 - 17:19
Perth based medical imaging technology and biotechnology company Visiomed Group Ltd has announced a capital raising of approximately $1.6 million.
This will take place through the placement of up to 90 million shares at 2 cents each and the Prospectus is expected to be lodged in the next 2 days.
The capital raising will primarily be used for expanding Funhaler asthma spacer into the European and US markets and will supplement existing working capital.
eG Capital Pty Ltd, an independent full service investment advisory company in the biotechnology and life science sector, will assist Visiomed in the capital raising.
Companies: